Company Filing History:
2 out of 2,971 
1 out of 98 
1 out of 1 Years Active: 1994-1997
Title: Edmund C Lin: Innovator in Nucleic Acid Detection
Introduction
Edmund C Lin is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of molecular biology, particularly in the detection of pathogenic organisms. With a total of 5 patents, his work has advanced the methodologies used in quantitative detection of specific nucleic acid sequences.
Latest Patents
One of his latest patents is focused on the quantitative detection of specific nucleic acid sequences using lambdoid. This invention provides compositions, methods, and kits for the detection and quantitation of pathogenic organisms. The composition includes an oligonucleotide probe that is covalently linked to a bacteriophage, allowing for the quantitation of pathogenic organisms present in biological fluid samples. Another notable patent involves a modified lambda bacteriophage, which includes a chemically modified tail protein that can be used to detect molecules of interest in solutions.
Career Highlights
Throughout his career, Edmund C Lin has worked with prestigious institutions such as Harvard College and Hybridon, Inc. His innovative approaches have led to advancements in the detection of pathogenic organisms, showcasing his expertise in the field.
Collaborations
He has collaborated with notable individuals in his field, including Bryan L Ray and Roberto Crea. These collaborations have further enriched his research and contributions to molecular biology.
Conclusion
Edmund C Lin's work in the field of nucleic acid detection has made a significant impact on the scientific community. His innovative patents and collaborations highlight his dedication to advancing molecular biology.